| 1 | 1 | | 1 of 1 |
|---|
| 2 | 2 | | SENATE DOCKET, NO. 1886 FILED ON: 1/20/2023 |
|---|
| 3 | 3 | | SENATE . . . . . . . . . . . . . . No. 1430 |
|---|
| 4 | 4 | | The Commonwealth of Massachusetts |
|---|
| 5 | 5 | | _________________ |
|---|
| 6 | 6 | | PRESENTED BY: |
|---|
| 7 | 7 | | Michael O. Moore |
|---|
| 8 | 8 | | _________________ |
|---|
| 9 | 9 | | To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General |
|---|
| 10 | 10 | | Court assembled: |
|---|
| 11 | 11 | | The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill: |
|---|
| 12 | 12 | | An Act relative to hormonal contraceptives. |
|---|
| 13 | 13 | | _______________ |
|---|
| 14 | 14 | | PETITION OF: |
|---|
| 15 | 15 | | NAME:DISTRICT/ADDRESS :Michael O. MooreSecond WorcesterVanna Howard17th Middlesex2/28/2023Rebecca L. RauschNorfolk, Worcester and Middlesex3/8/2023 1 of 3 |
|---|
| 16 | 16 | | SENATE DOCKET, NO. 1886 FILED ON: 1/20/2023 |
|---|
| 17 | 17 | | SENATE . . . . . . . . . . . . . . No. 1430 |
|---|
| 18 | 18 | | By Mr. Moore, a petition (accompanied by bill, Senate, No. 1430) of Michael O. Moore, Vanna |
|---|
| 19 | 19 | | Howard and Rebecca L. Rausch for legislation relative to hormonal contraceptives. Public |
|---|
| 20 | 20 | | Health. |
|---|
| 21 | 21 | | [SIMILAR MATTER FILED IN PREVIOUS SESSION |
|---|
| 22 | 22 | | SEE SENATE, NO. 1487 OF 2021-2022.] |
|---|
| 23 | 23 | | The Commonwealth of Massachusetts |
|---|
| 24 | 24 | | _______________ |
|---|
| 25 | 25 | | In the One Hundred and Ninety-Third General Court |
|---|
| 26 | 26 | | (2023-2024) |
|---|
| 27 | 27 | | _______________ |
|---|
| 28 | 28 | | An Act relative to hormonal contraceptives. |
|---|
| 29 | 29 | | Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority |
|---|
| 30 | 30 | | of the same, as follows: |
|---|
| 31 | 31 | | 1 SECTION 1. Chapter 94C, as appearing in the 2020 Official Edition, is hereby amended |
|---|
| 32 | 32 | | 2by inserting, after section 19D, the following section:- |
|---|
| 33 | 33 | | 3 Section 19E. A registered pharmacist may prescribe and dispense hormonal contraceptive |
|---|
| 34 | 34 | | 4patches and self-administered oral hormonal contraceptives to a person who is: |
|---|
| 35 | 35 | | 5 (a) At least 18 years of age, regardless of whether the person has evidence of a previous |
|---|
| 36 | 36 | | 6prescription from a primary care practitioner or women’s health care practitioner for a hormonal |
|---|
| 37 | 37 | | 7contraceptive patch or self-administered oral hormonal contraceptive; or 2 of 3 |
|---|
| 38 | 38 | | 8 (b) Under 18 years of age, only if the person has evidence of a previous prescription from |
|---|
| 39 | 39 | | 9a primary care practitioner or women’s health care practitioner for a hormonal contraceptive |
|---|
| 40 | 40 | | 10patch or self-administered oral hormonal contraceptive. |
|---|
| 41 | 41 | | 11 The board shall adopt rules to establish, in consultation with the Massachusetts Medical |
|---|
| 42 | 42 | | 12Board, the Massachusetts State Board of Nursing and the MassHealth, and in consideration of |
|---|
| 43 | 43 | | 13guidelines established by the American Congress of Obstetricians and Gynecologists, standard |
|---|
| 44 | 44 | | 14procedures for the prescribing of hormonal contraceptive patches and self-administered oral |
|---|
| 45 | 45 | | 15hormonal contraceptives by pharmacists. The rules adopted under this subsection must require a |
|---|
| 46 | 46 | | 16pharmacist to: |
|---|
| 47 | 47 | | 17 (a) Complete a training program approved by the State Board of Pharmacy that is related |
|---|
| 48 | 48 | | 18to prescribing hormonal contraceptive patches and self-administered oral hormonal |
|---|
| 49 | 49 | | 19contraceptives; |
|---|
| 50 | 50 | | 20 (b) Provide a self-screening risk assessment tool that the patient must use prior to the |
|---|
| 51 | 51 | | 21pharmacist’s prescribing the hormonal contraceptive patch or self-administered oral hormonal |
|---|
| 52 | 52 | | 22contraceptive; |
|---|
| 53 | 53 | | 23 (c) Refer the patient to the patient’s primary care practitioner or women’s health care |
|---|
| 54 | 54 | | 24practitioner upon prescribing and dispensing the hormonal contraceptive patch or self- |
|---|
| 55 | 55 | | 25administered oral hormonal contraceptive; |
|---|
| 56 | 56 | | 26 (d) Provide the patient with a written record of the hormonal contraceptive patch or self- |
|---|
| 57 | 57 | | 27administered oral hormonal contraceptive prescribed and dispensed and advise the patient to |
|---|
| 58 | 58 | | 28consult with a primary care practitioner or women’s health care practitioner; and 3 of 3 |
|---|
| 59 | 59 | | 29 (e) Dispense the hormonal contraceptive patch or self-administered oral hormonal |
|---|
| 60 | 60 | | 30contraceptive to the patient as soon as practicable after the pharmacist issues the prescription. |
|---|
| 61 | 61 | | 31 The rules adopted must prohibit a pharmacist from: |
|---|
| 62 | 62 | | 32 (a) Requiring a patient to schedule an appointment with the pharmacist for the |
|---|
| 63 | 63 | | 33prescribing or dispensing of a hormonal contraceptive patch or self-administered oral hormonal |
|---|
| 64 | 64 | | 34contraceptive; and |
|---|
| 65 | 65 | | 35 (b) Prescribing and dispensing a hormonal contraceptive patch or self-administered oral |
|---|
| 66 | 66 | | 36hormonal contraceptive to a patient who does not have evidence of a clinical visit for women’s |
|---|
| 67 | 67 | | 37health within the three years immediately following the initial prescription and dispensation of a |
|---|
| 68 | 68 | | 38hormonal contraceptive patch or self-administered oral hormonal contraceptive by a pharmacist |
|---|
| 69 | 69 | | 39to the patient. |
|---|